On December 1, 2023, Baillie Gifford (Trades, Portfolio), a renowned investment management firm, made a significant adjustment to its holdings in Certara Inc (NASDAQ:CERT), a key player in the biosimulation software and technology sector. This transaction had a negligible impact on Baillie Gifford (Trades, Portfolio)'s portfolio, with the trade executed at a price of $14.64 per share. Despite the reduction, Baillie Gifford (Trades, Portfolio) maintains a 5.58% position in Certara, reflecting a 0.12% ratio of the traded stock in the firm's overall portfolio.
Baillie Gifford (Trades, Portfolio), a renowned investment management firm, has recently increased its investment in Moderna Inc (NASDAQ:MRNA), a leader in the biotechnology industry. This transaction has brought Baillie Gifford (Trades, Portfolio)'s total share count in Moderna to 45,654,527, representing a significant position size of 3.33% in the firm's portfolio and 11.97% of the firm's holdings in the traded stock.
On December 1, 2023, Baillie Gifford (Trades, Portfolio), a renowned investment management firm, made a significant adjustment to its investment portfolio by reducing its stake in Alnylam Pharmaceuticals Inc (NASDAQ:ALNY). The transaction involved the sale of 1,196,042 shares, which resulted in a 14.65% decrease in Baillie Gifford (Trades, Portfolio)'s holdings in the company.
Baillie Gifford (Trades, Portfolio), a renowned investment management firm, has recently made a significant adjustment to its holdings in Staar Surgical Co (NASDAQ:STAA). On December 1, 2023, the firm reduced its position in the company, signaling a strategic shift in its investment portfolio. This move by Baillie Gifford (Trades, Portfolio) has caught the attention of investors and market analysts alike, as it reflects the firm's ongoing portfolio management decisions.
On December 1, 2023, Baillie Gifford (Trades, Portfolio), a prominent investment management firm, executed a reduction in its holdings of Wayfair Inc (NYSE:W), an e-commerce giant in the home goods sector. Following the trade, Baillie Gifford (Trades, Portfolio)'s remaining stake in Wayfair Inc amounts to 7,428,995 shares, which represents 0.4% of its portfolio and 8.05% of the company's shares.